Related Experiment Video
Updated: Sep 20, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
[Severity Classification of Moyamoya Disease]
1Department of Neurosurgery, Kindai University Faculty of Medicine.
Moyamoya disease (a rare neurological disorder) criteria were revised in 2024. The updated guidelines now focus on future medical needs rather than solely on fixed symptoms for eligibility.
Area of Science:
- Neurology
- Public Health Policy
Background:
- Moyamoya disease is a Specified Intractable Disease in Japan.
- Current criteria established in 2014 exclude patients with mild, non-persistent symptoms, or those post-bypass surgery for over 5 years.
Purpose of the Study:
- To revise the eligibility criteria for Moyamoya disease certification.
- To ensure patients with potential future medical needs are adequately covered.
Main Methods:
- Initiation of a revision by the Moyamoya Disease Research Group in 2021.
- Official revision passed in 2024.
Main Results:
- The primary change is a shift in focus from fixed symptoms to future medical needs.
- This revision aims to broaden eligibility for Moyamoya disease certification.
Conclusions:
- The updated criteria better reflect the dynamic nature of Moyamoya disease.
- The revision enhances support for patients by prioritizing their ongoing and future healthcare requirements.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Cardiomyopathy I: Introduction and Classification
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Heart Failure IV: Classification and Diagnostic Evaluation
Angina II: Classification
Mitral Stenosis II: Clinical features and Diagnostic Tests

